The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more resilient to significant structural changes than was previously thought.

Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation CRISPR gene editing platform to create potential one-time curative therapies, today announced new ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.